年轻患者的故意过量服用模式:加拿大北克的一项回顾性队列研究 (2020-2022年)
Audrée Elliott1, Isabelle Bilodeau2, Caroline Sirois3,4
1Centre antipoison du Québec, CIUSSS Capitale Nationale, Québec City, Québec, Canada.
Paediatrics & child health
|September 8, 2025
概括
加拿大年轻人中故意自我伤害的中毒事件正在增加,乙氨基和抗抑郁药物是常见的物质. 预防工作应专注于安全的药物储存和管理,特别是针对年轻人的药物.
科学领域:
- 公共卫生 公共卫生
- 毒理学 毒理学 毒理学
- 儿科 儿科 儿科
背景情况:
- 自杀和自我伤害是加拿大死亡的重要原因,特别是在年轻人中.
- 毒品中心的数据显示,有意自伤的中毒病例有所增加,尤其影响年轻人.
研究的目的:
- 分析北克儿童和青少年故意自我伤害中毒病例的趋势和特征.
- 确定涉及的常见物质和结果,以告知预防策略.
主要方法:
- 使用北克毒药中心的ToxiQc数据库的数据进行了一项回顾性队列研究.
- 分析了2020年1月1日至2022年12月31日期间6-19岁个人自伤的情况.
- 描述性统计数据被用来检查人口统计,物质暴露和结果.
主要成果:
- 该研究包括5241例病例,主要是女性 (84.7%),平均年龄为15.9岁.
- 乙氨基,抗抑郁药和NSAID是最常涉及的物质.
- 在这两个年龄组中,在与天然保健产品相关的自我伤害病例中,黑的存在尤为明显.
结论:
- 无处方药和处方药的可用性可能有助于在自伤事件中使用这些药物.
- 建议包括教育医疗保健专业人员和家长安全的药物储存和监督儿童药物管理.
相关概念视频
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
256
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
256
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233
Drug Dosing: Infants and Children
257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution
258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


